HealthBayer Seeks FDA Approval For Regorafenib As Liver Cancer Treatment German drugmaker Bayer on Monday submitted an sNDA proposal to the FDA for the extension of its drug Regorafenib as a second-line treatment for liver cancer. The drug is currently used to treat colorectal cancer.by Alyssa Navarro
Healthy Living/WellnessStudy Raises Safety Concern About Bayer Sterilization Device: Essure Tied With Increased Need For Reoperationsby Julienne Roman
Healthy Living/WellnessReports Of Health Complications Prompt FDA To Review Safety Of Essure Birth Control Implantby Julienne Roman
Healthy Living/WellnessBayer Pushes Heart Failure Drug Finerenone To Final-Stage Trialsby Rina Marie Doctor
Healthy Living/WellnessCourt awards Chicago woman $14 mn in damages after taking wrongly prescribed Yasmin contraceptiveby Rhodi Lee
Healthy Living/WellnessProstate cancer drug Xofigo not recommended by British authorities due to cost effectiveness issuesby Lori Sandoval
Are Majority of Your Online Apps Down? Massive Internet Outage Affects Spotify, Twitch, Google, and More